AGRX - アジャイル・セラピュ―ティクス (Agile Therapeutics Inc.) アジャイル・セラピュ―ティクス

 AGRXのチャート


 AGRXの企業情報

symbol AGRx
会社名 Agile Therapeutics Inc (アジャイル・セラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 アジャイル・セラピューティクス(Agile Therapeutics Inc.)は女性の健康向けスペシャリティ医薬品企業。同社は、新規処方避妊製品の開発と商業化に焦点を当てる。同社の製品候補は、利便性を提供し、コンプライアンスを促進する避妊オプションを女性に提供するために設計される。同社のリード製品候補の「Twirla」はまた「AG200-15」として知られ、フェーズⅢ臨床開発にある週一回の処方避妊パッチである。「Twirla」は、利用可能なパッチを上回る利点を提供するように設計され、パッチの密着性・安定性と患者の快適性を最適化するように意図される「Skinfusion」という経皮パッチ技術に基づく。「Twirla」は、プロゲスチンの一種の合成ステロイドホルモンであるレボノルゲストレル(LNG)、及び合成エストロゲンである有効成分のエチニルエストラジオール(EE)を含有する複合ホルモン避妊薬(CHC)パッチである。   アジャイル・セラピュ―ティクスは、女性のヘルスケア製品に特化した米国の医薬品開発会社。新規処方避妊製品の開発と商業化に注力する。避妊用の経皮パッチ技術「スキンフュ―ジョン」を研究・開発する。同社の製品候補である避妊パッチ「Twirla(別名AG200-15)」は、避妊を選択する女性に利便性を提供し、迎合性を容易にする。  Agile Therapeutics is a forward-looking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. Its product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. The Company's initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on Company's proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. The Company may occasionally disseminate material, nonpublic information on the Company's website.
本社所在地 101 Poor Farm Road Princeton NJ 08540 USA
代表者氏名 Alfred Altomari アルフレッドアルトマリ
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 609-683-1880
設立年月日 35765
市場名 NASDAQ National Market System
ipoyear 2014年
従業員数
url www.agiletherapeutics.com
nasdaq_url https://www.nasdaq.com/symbol/agrx
adr_tso
EBITDA EBITDA(百万ドル) -24.44100
終値(lastsale) 0.46
時価総額(marketcap) 15813571.34
時価総額 時価総額(百万ドル) 24.40790
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 9.46790
当期純利益 当期純利益(百万ドル) -25.51900
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Agile Therapeutics Inc revenues was not reported. Net loss decreased 19% to $12.2M. Lower net loss reflects Other Research and Development decrease of 28% to $5.7M (expense) Other General and administrative decrease of 10% to $4M (expense) Interest expense decrease of 34% to $688K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.52 to -$0.36.

 AGRXのテクニカル分析


 AGRXのニュース

   Results from Agile Therapeutics Inc. (AGRX) show risk  2022/09/26 13:32:00 US Post News
Agile Therapeutics Inc. (NASDAQ:AGRX) closed Friday at $0.28 per share, down from $0.30 a day earlier. While Agile Therapeutics Inc. has underperformed by -8.12%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AGRX fell by -99.32%, with highs and lows ranging from $42.00 to $0.28, whereas […]
   Agile Therapeutics Inc. (NASDAQ:AGRX) Shares Are Down -13.33% From The Lows, But Can They Stay Up?  2022/09/23 15:00:00 Marketing Sentinel
In last trading session, Agile Therapeutics Inc. (NASDAQ:AGRX) saw 2.37 million shares changing hands with its beta currently measuring 1.21. Company’s recent per share price level of $0.30 trading at -$0.04 or -11.20% at ring of the bell on the day assigns it a market valuation of $65.76M. That closing price of AGRX’s stock is … Agile Therapeutics Inc. (NASDAQ:AGRX) Shares Are Down -13.33% From The Lows, But Can They Stay Up? Read More »
   What To Expect As Agile Therapeutics Inc. (NASDAQ: AGRX) Delivers An -95.92% Loss In 6 Months  2022/09/15 15:30:00 Marketing Sentinel
During the last session, Agile Therapeutics Inc. (NASDAQ:AGRX)’s traded shares were 1.64 million, with the beta value of the company hitting 1.22. At the end of the trading day, the stock’s price was $0.39, reflecting an intraday loss of -3.14% or -$0.02. The 52-week high for the AGRX share is $44.00, that puts it down … What To Expect As Agile Therapeutics Inc. (NASDAQ: AGRX) Delivers An -95.92% Loss In 6 Months Read More »
   Agile Therapeutics (AGRX) presents at H.C. Wainwright 24th Annual Global Investment Conference - Slideshow (NASDAQ:AGRX)  2022/09/14 13:43:02 Seeking Alpha
The following slide deck was published by Agile Therapeutics, Inc.
   The Agile Therapeutics Inc. (AGRX) had a good session last reading, didn’t it?  2022/09/13 14:00:00 US Post News
The share price of Agile Therapeutics Inc. (NASDAQ:AGRX) fell to $0.39 per share on Monday from $0.40. While Agile Therapeutics Inc. has underperformed by -2.88%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AGRX fell by -99.17%, with highs and lows ranging from $50.40 to $0.37, […]
   Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022  2022/07/28 12:05:00 GlobeNewswire
Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET
   Outrageous stocks: Agile Therapeutics, Inc. (NASDAQ:AGRX 2.71%), Party City Holdco Inc. (NYSE:PRTY -9.13%)  2022/07/27 00:40:05 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Outrageous stocks: Agile Therapeutics, Inc. (NASDAQ:AGRX 2.71%), Party City Holdco Inc. (NYSE:PRTY -9.13%) appeared first on Stocks Equity .
   Maxim Group Upgrades Agile Therapeutics to Buy  2022/07/26 11:56:04 Investing.com
https://www.investing.com/news/pro/maxim-group-upgrades-agile-therapeutics-to-buy-432SI-2853994
   Agile Therapeutics Inc. (NASDAQ:AGRX) Is 11.67% Above Its 52-Week Low, But How Long Will It Remain So?  2022/07/22 15:30:00 Marketing Sentinel
In last trading session, Agile Therapeutics Inc. (NASDAQ:AGRX) saw 8.48 million shares changing hands with its beta currently measuring 1.61. Company’s recent per share price level of $0.60 trading at $0.01 or 1.86% at ring of the bell on the day assigns it a market valuation of $7.83M. That closing price of AGRX’s stock is … Agile Therapeutics Inc. (NASDAQ:AGRX) Is 11.67% Above Its 52-Week Low, But How Long Will It Remain So? Read More »
   Agile Therapeutics Inc. (NASDAQ: AGRX) Is Down -5.17% From Its 52-Week Low; YTD, It Is Down -97.03% – What To Do Now  2022/07/15 14:00:00 Marketing Sentinel
During the last session, Agile Therapeutics Inc. (NASDAQ:AGRX)’s traded shares were 9.94 million, with the beta value of the company hitting 1.52. At the end of the trading day, the stock’s price was $0.58, reflecting an intraday loss of -9.62% or -$0.06. The 52-week high for the AGRX share is $53.20, that puts it down … Agile Therapeutics Inc. (NASDAQ: AGRX) Is Down -5.17% From Its 52-Week Low; YTD, It Is Down -97.03% – What To Do Now Read More »
   Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022  2022/05/03 11:30:00 GlobeNewswire
Live Conference Call and Webcast at 4:30 p.m. ET Live Conference Call and Webcast at 4:30 p.m. ET
   Agile Therapeutics to raise $13M in stock offering, provides certain Q1 estimates and reverse stock split effective Apr.27  2022/04/27 12:38:56 Seeking Alpha
Agile Therapeutics (AGRX) entered into a sales agreement to sell up to $12.84M of shares of stock, par value $0.0001/share, through a sales agent.The company cannot provide any…
   71 Biggest Movers From Yesterday  2022/04/27 08:27:24 Benzinga
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK ) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma''s Gimoti (metoclopramide) nasal spray to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults. Nutex Health, Inc. (NASDAQ: NUTX ) gained 73.8% to close at $7.68 on above-average volume despite no company-specific news. Cyngn Inc. (NASDAQ: CYN ) jumped 52.1% to close at $3.68 on above-average volume despite no company-specific news to justify the price action. Forge Global Holdings, Inc. (NYSE: FRGE ) gained 40.4% to close at $18.46 on above-average volume. GeoVax Labs, Inc. (NASDAQ: GOVX ) jumped 29.8% to settle at $1.11. The U.S. Patent and Trademark Office issued Patent No. 11,311,612 covering GeoVax Labs modified vaccinia Ankara (MVA) vector expressing certain antigens from the malaria parasite. Jiuzi Holdings, Inc. (NASDAQ: JZXN ) gained 27.3% to close at $1.68 after the company announced it entered into an equity acquisition agreement to acquire an automobile sales serviceshop operator under top china automaker Geely Auto''s premium electronic vehicle brand Geometry.
   Thinking about buying stock in Agile Therapeutics, Evoke Pharma, Warner Bros Discovery, Nkarta, or Sky Harbour?  2022/04/26 14:55:00 Benzinga
NEW YORK , April 26, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AGRX, EVOK, WBD, NKTX, and SKYH. … Full story available on Benzinga.com
   Agile Therapeutics stock gains on 1-for-40 reverse stock split  2022/04/26 12:13:49 Seeking Alpha
Agile Therapeutics (AGRX) shares surged ~30% pre-market after the women''s healthcare company announced a 1-for-40 reverse stock split, effective 5:00 p.m

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 アジャイル・セラピュ―ティクス AGRX Agile Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)